Skip to content

Muscle and Cerebral Oxygenation Under EVAR of AAA: GA vs LA

Muscle and Cerebral Oxygenation Under Endovascular Aortic Repair (EVAR) of Abdominal Aortic Aneurysm: General Versus Local Anesthesia - an Randomised Controlled Trial Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02555046
Enrollment
26
Registered
2015-09-21
Start date
2015-10-31
Completion date
2018-07-31
Last updated
2015-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Keywords

Spectroscopy, Near-Infrared, Endovascular Procedures, Local Anesthesia, General Anesthesia

Brief summary

The purpose of this study is to determine the effect of General versus Local Anaesthesia on muscle and cerebral oxygenation under EVAR-treatment in a prospective unblinded randomised controlled trail.

Interventions

PROCEDURELocal Anesthesia

Use of unspecified local anaesthesia (fx lidocain or bupivacaine)

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older * Scheduled procedure

Exclusion criteria

* allergies for used local anaesthesia * have had vascular surgery before in the femoral area * the need for thromboendarterectomy in common femoral artery * the need for aortouniiliac stent-graft with cross-over bypass * severe back pain * expected time of surgery more than 1.5 hour * cognitive dysfunction making cooperation during procedure impossible * Femoral amputee

Design outcomes

Primary

MeasureTime frame
Near-Infrared Spectroscopy-determined Cerebral Oxygenationparticipants will be followed for the duration of hospital stay, an expected average of 5 days
Near-Infrared Spectroscopy-determined Muscle oxygenationparticipants will be followed for the duration of hospital stay, an expected average of 5 days

Contacts

Primary ContactMads J Niemann, Student
mads.jacob.niemann@regionh.dk004560633752
Backup ContactHenning B Nielsen, MD, PhD
henning.morris.bay.nielsen@regionh.dk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026